Mead Johnson Launches Enfinitas® in China
March 28 2016 - 6:06AM
Business Wire
Premium offering features ingredients based on
breakthrough science
Mead Johnson Nutrition Company (NYSE:MJN) today announced the
launch of its new Enfinitas premium-priced product line in China,
which will be rolling out in that market over the coming weeks.
“As noted previously, Mead Johnson continually strives to
further broaden our science-based product portfolio,” commented
Kasper Jakobsen, President and CEO. “We are pleased to be
introducing Enfinitas and its meaningful benefits to consumers in
China in support of our mission to help nourish the world’s
children for the best start in life. Over time, we expect this
product to strengthen our competitiveness in the fastest-growing
segment of our category in China.”
Enfinitas adopts the very latest science and advanced technology
in infant nutrition and is inspired by Mead Johnson’s comprehensive
global research and findings in human milk. That research, which
has accelerated over the past five years, has been carried out in
cooperation with multiple authoritative scientific research
institutions in studies covering populations in Asia, Europe, North
America and South America.
Specifically customized for the China market and produced in the
Netherlands, this new formulation has undergone extensive research.
Enfinitas contains Lactoferrin and Milk Fat Globule Membrane (MFGM)
– both of which are naturally present in breast milk and known to
provide structural and functional benefits to infants. Together
with the company’s gold standard level of DHA, these critical
components help support brain development, immune system function
and digestive health.
Additional information will be provided on the Mead Johnson
Nutrition 2016 first quarter earnings conference call.
About Mead Johnson
Nutrition
Mead Johnson, a global leader in pediatric nutrition, develops,
manufactures, markets and distributes more than 70 products in over
50 markets worldwide. The company’s mission is to nourish the
world’s children for the best start in life. The Mead Johnson name
has been associated with science-based pediatric nutrition products
for over 110 years. The company’s “Enfa” family of brands,
including Enfamil® infant formula, is the world’s leading brand
franchise in pediatric nutrition. For more information, go to
www.meadjohnson.com.
Forward-Looking
Statements
Certain statements in this news release are forward-looking as
defined in the Private Securities Litigation Reform Act of 1995.
These forward-looking statements may be identified by the fact they
use words such as “should,” “expect,” “anticipate,” “estimate,”
“target,” “may,” “project,” “guidance,” “intend,” “plan,” “believe”
and other words and terms of similar meaning and expression. Such
statements are likely to relate to, among other things, a
discussion of goals, plans and projections regarding financial
position, results of operations, cash flows, market position,
product development, product approvals, sales efforts, expenses,
capital expenditures, performance or results of current and
anticipated products and the outcome of contingencies such as legal
proceedings and financial results. Forward-looking statements can
also be identified by the fact that they do not relate strictly to
historical or current facts. Such forward-looking statements are
based on current expectations that involve inherent risks,
uncertainties and assumptions that may cause actual results to
differ materially from expectations as of the date of this news
release. These risks include, but are not limited to: (1) the
ability to sustain brand strength, particularly the Enfa family of
brands; (2) the effect on the company's reputation of real or
perceived quality issues; (3) the effect of regulatory restrictions
related to the company’s products; (4) the adverse effect of
commodity costs; (5) increased competition from branded, private
label, store and economy-branded products; (6) the effect of an
economic downturn on consumers' purchasing behavior and customers'
ability to pay for product; (7) inventory reductions by customers;
(8) the adverse effect of changes in foreign currency exchange
rates; (9) the effect of changes in economic, political and social
conditions in the markets where we operate; (10) changing consumer
preferences; (11) the possibility of changes in the WIC* program,
or participation in WIC; (12) legislative, regulatory or judicial
action that may adversely affect the company's ability to advertise
its products, maintain product margins, or negatively impact the
company’s reputation or result in fines or penalties that decrease
earnings; and (13) the ability to develop and market new,
innovative products. For additional information regarding these and
other factors, see the company’s filings with the United States
Securities and Exchange Commission (the SEC), including its most
recent Annual Report on Form 10-K, which filings are available upon
request from the SEC or at www.meadjohnson.com. The company
cautions readers not to place undue reliance on any forward-looking
statements, which speak only as of the date made. The company
undertakes no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events or
otherwise.
* The Special Supplemental Nutrition Program for Women, Infants
and Children (WIC) is a federal assistance program of the Food and
Nutrition Services (FNS) of the United States Department of
Agriculture (USDA).
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160328005320/en/
Mead Johnson Nutrition CompanyInvestors:Kathy MacDonald, (847)
832-2182kathy.macdonald@mjn.comorMedia:Christopher Perille, (847)
832-2178chris.perille@mjn.com
Morgan Stanley DW Str Sat Att (NYSE:MJN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Morgan Stanley DW Str Sat Att (NYSE:MJN)
Historical Stock Chart
From Apr 2023 to Apr 2024